Narcotics research, rehabilitation, and treatment. Hearings, Ninety ...

Narcotics research, rehabilitation, and treatment. Hearings, Ninety ... Narcotics research, rehabilitation, and treatment. Hearings, Ninety ...

library.whnlive.com
from library.whnlive.com More from this publisher
12.07.2015 Views

506of urine testing, plus psychotherapy provided in a weekly groiq)j)sycho therapy meeting.The gentlemen on my left and right are individuals who participateilin such a program and shortly will give you some of their impressionson the benefit of their experiences.In the survey of just exactly what happened to these individuals,following their release from a correctional institution, we learned that85 percent of these individuals will reexpose themselves to a narcoticexperience within 12 weeks after release from a correctional institutiondespite the fact that they face the possibility of being returnedto jail.In exploring this matter further we also learned that despite thefact that 85 percent will reexpose themselves to a narcotic experience,there were only 15 percent that indicated so little control that theyimmediately relapsed into continuing drug use that necessitated theirimmediate removal from the program.The great majority attempted to cope with this need for or urgefor drugs through intermittent episodes of exposure and then becomingabstinent for a varying period.As we became acquainted with this pattern of behavior and soughtmore effective therapeutic means for coping with this disorder, wewere very fortunate in becoming aware of some of the experimentswith naloxone being carried out by a New York group of researchersunder the leadership of Drs. Max Fink and A. M. Freedman, whohad learned that large doses of naloxone, namely, between 2,000 and2,500 milligrams, administered on a daily basis, would provide atotal blockage lasting for a period of 24 hours. However, this raiseda very formidable problem because of the costliness and scarcity ofsupplies of the naloxone handicapping expanded investigation.Since our investigations had outlined some of the patterns of theepisodic and intermittent usage, it was suggested, in view of thescarcity of naloxone, that a compromise might be effected b}^ utilizinga system of low dosage, although this yielded only partialblockade.Employing this aj^proach, it was learned that the low dosageblockade did not appear to achieve a greater level of retention thanabstinence alone in retaining individuals in the program. The longerthe individual was retained in the program, the more meaningfulthis was felt to be. The hypothesis had been that a dosage range ofbetween 200 and 800 milligrams, given only at night, would blockadethe ev^ening hours, a time when these individuals were considered to bemost vulnerable to drug usage since all were requu'ed to maintain ajob as a condition of their parole.We found in the course of the pilot study that we could administerthe naloxone either up or down the scale of dosage very (piicklywithout any Ul or particular disturbing effects on the patients,although the effects were short lived; namely, 3 to 5 hours. In thecourse of this treatment many of the individuals soon learneil tobypass this period of time through their self-experimentation, discoveringif they gave the drug beyond this time interval they couldstill get their high.As we revievved the results of the pilot investigation and totaledthe dosages of naloxone that had been used in this experiment, we

507discovered if we iiad taken the same dosage and given this total dosagejust as those points in time when these individuals had experienceda stress—resorted to drug usage—it would perhaps been moremeaningful to have used the naloxone in a manner similar to thatused for penicillin.When an individual resorted to opiate usage, as revealed by dailymonitoring, and this extended over a j)eriod of 2 or 3 days, the blockadewould be carried out with an administration of high dosage, 2,500milligrams, until he once more became abstinent. Usually this couldbe anticipated to occur within a period of 2 or 3 days, with the individualonce more continuing his abstinent course.We feel that with adequate supplies of this drug that we couldapproach this disorder on the same basis we deal with an infection;that is, as the individual reached a point where he was exposing himselfto drugs he would, at this time, be administered sufficient naloxoneto provide him with total blockade and the naloxone discontinuedwith the return to abstinence. Following this, there might be anotherperiod of weeks or months before reexposing himself again. You mustremember, we are dealing with a chronic disorder which, as yet, wedo not know how to treat effectively, nor do we know what causesthis disorder.With that brief introduction, sir, I would like to turn to some ofthe gentlemen accompanying me who have been kind enough to volunteerto express their thoughts and feelings.Chaimian Pepper. Would you care to give their names or wouldthev i)refer not to?Dr. KuRLAND. They indicated a willingness to present their nameand identify themselves. I w'ill start with the gentleman on my rightand this is Mr. McCoy.STATEMENT OF WILLIAM McCOYMr. McCoy. My name is WiUiam McCoy and I have been anaddict for over 25 years. I have been in and out of different institutionsgoing back to the year 1939. And up until recently I have never beengiven a chance on parole or anything of that nature as far as helpingme or having any ideas of wanting to help myself. Dr. Kurland andhis program started the thing about taking addicts out of the institutionson an outpatient basis, and I was accepted on this becauseof the fact that I showed potentials of wanting to leave drugs alone.Now, when I first came home, for the first month or two, I did verygood and then an incident happened about a friend of mine that gotkilled and I went back into a rut and for about a period of 3 or 4months I went back to drugs.Then I volunteered for this naloxone program and I stayed on thatfor a period of 6 months and as of the present date I have been drugfree for over a period of a year and have not had the urge to takedrugs nor do I want drugs any more. And personally s])eaking, I saythat this medicine, naloxone, has shown to me that it is a good deterrentfor the usage of the drugs because the first night I had takenthe naloxone I had drugs in my system and 5 minutes after I hadtaken it, it made me ill. I threw up all the drugs, brought the drugsout of my system, and I began to realize if I were to continue to take

506of urine testing, plus psychotherapy provided in a weekly groiq)j)sycho therapy meeting.The gentlemen on my left <strong>and</strong> right are individuals who participateilin such a program <strong>and</strong> shortly will give you some of their impressionson the benefit of their experiences.In the survey of just exactly what happened to these individuals,following their release from a correctional institution, we learned that85 percent of these individuals will reexpose themselves to a narcoticexperience within 12 weeks after release from a correctional institutiondespite the fact that they face the possibility of being returnedto jail.In exploring this matter further we also learned that despite thefact that 85 percent will reexpose themselves to a narcotic experience,there were only 15 percent that indicated so little control that theyimmediately relapsed into continuing drug use that necessitated theirimmediate removal from the program.The great majority attempted to cope with this need for or urgefor drugs through intermittent episodes of exposure <strong>and</strong> then becomingabstinent for a varying period.As we became acquainted with this pattern of behavior <strong>and</strong> soughtmore effective therapeutic means for coping with this disorder, wewere very fortunate in becoming aware of some of the experimentswith naloxone being carried out by a New York group of <strong>research</strong>ersunder the leadership of Drs. Max Fink <strong>and</strong> A. M. Freedman, whohad learned that large doses of naloxone, namely, between 2,000 <strong>and</strong>2,500 milligrams, administered on a daily basis, would provide atotal blockage lasting for a period of 24 hours. However, this raiseda very formidable problem because of the costliness <strong>and</strong> scarcity ofsupplies of the naloxone h<strong>and</strong>icapping exp<strong>and</strong>ed investigation.Since our investigations had outlined some of the patterns of theepisodic <strong>and</strong> intermittent usage, it was suggested, in view of thescarcity of naloxone, that a compromise might be effected b}^ utilizinga system of low dosage, although this yielded only partialblockade.Employing this aj^proach, it was learned that the low dosageblockade did not appear to achieve a greater level of retention thanabstinence alone in retaining individuals in the program. The longerthe individual was retained in the program, the more meaningfulthis was felt to be. The hypothesis had been that a dosage range ofbetween 200 <strong>and</strong> 800 milligrams, given only at night, would blockadethe ev^ening hours, a time when these individuals were considered to bemost vulnerable to drug usage since all were requu'ed to maintain ajob as a condition of their parole.We found in the course of the pilot study that we could administerthe naloxone either up or down the scale of dosage very (piicklywithout any Ul or particular disturbing effects on the patients,although the effects were short lived; namely, 3 to 5 hours. In thecourse of this <strong>treatment</strong> many of the individuals soon learneil tobypass this period of time through their self-experimentation, discoveringif they gave the drug beyond this time interval they couldstill get their high.As we revievved the results of the pilot investigation <strong>and</strong> totaledthe dosages of naloxone that had been used in this experiment, we

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!